Ioversol 320: A new nonionic, water-soluble contrast medium for body computed tomography: Clinical trial

Kenyon K. Kopecky, Gary J. Becker, Dewey Conces

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

An open-label noncomparative clinical study was conducted to evaluate the safety, tolerance, and efficacy of ioversol (Optiray® 320), a new low-osmolality nonionic contrast medium used in contrast-enhanced computed tomographic (CT) scanning. Forty-two adult patients who required contrast-enhanced body CT scanning participated in the study. Ioversol was administered to patients undergoing CT of the chest, abdomen, and pelvis. Most of the patients received a dose of 150 mL, with smaller doses administered if a patient weighed less than 50 kg or if a patient had only one functioning kidney. The quality of the CT scans was judged to be diagnostic in all 42 patients in the study, with the quality assessed as excellent in 35 patients and good in seven patients. Ioversol was considered well tolerated by patients in the study, with none reporting any pain from the contrast agent. Only mild or moderate sensations of heat were reported. There were no clinically significant changes in vital signs, and only one mild adverse reaction (determined to be procedure-related) was reported. Ioversol was found to be safe, well tolerated, and efficacious for use in body CT scanning.

Original languageEnglish (US)
Pages (from-to)S33-S34
JournalInvestigative Radiology
Volume24
StatePublished - 1989

Fingerprint

ioversol
Contrast Media
Tomography
Clinical Trials
Water
Vital Signs

Keywords

  • Computed tomographic scanning
  • Contrast medium
  • Ioversol

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Ioversol 320 : A new nonionic, water-soluble contrast medium for body computed tomography: Clinical trial. / Kopecky, Kenyon K.; Becker, Gary J.; Conces, Dewey.

In: Investigative Radiology, Vol. 24, 1989, p. S33-S34.

Research output: Contribution to journalArticle

@article{b426a99b19ac4cf083fb1fc782da07b4,
title = "Ioversol 320: A new nonionic, water-soluble contrast medium for body computed tomography: Clinical trial",
abstract = "An open-label noncomparative clinical study was conducted to evaluate the safety, tolerance, and efficacy of ioversol (Optiray{\circledR} 320), a new low-osmolality nonionic contrast medium used in contrast-enhanced computed tomographic (CT) scanning. Forty-two adult patients who required contrast-enhanced body CT scanning participated in the study. Ioversol was administered to patients undergoing CT of the chest, abdomen, and pelvis. Most of the patients received a dose of 150 mL, with smaller doses administered if a patient weighed less than 50 kg or if a patient had only one functioning kidney. The quality of the CT scans was judged to be diagnostic in all 42 patients in the study, with the quality assessed as excellent in 35 patients and good in seven patients. Ioversol was considered well tolerated by patients in the study, with none reporting any pain from the contrast agent. Only mild or moderate sensations of heat were reported. There were no clinically significant changes in vital signs, and only one mild adverse reaction (determined to be procedure-related) was reported. Ioversol was found to be safe, well tolerated, and efficacious for use in body CT scanning.",
keywords = "Computed tomographic scanning, Contrast medium, Ioversol",
author = "Kopecky, {Kenyon K.} and Becker, {Gary J.} and Dewey Conces",
year = "1989",
language = "English (US)",
volume = "24",
pages = "S33--S34",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Ioversol 320

T2 - A new nonionic, water-soluble contrast medium for body computed tomography: Clinical trial

AU - Kopecky, Kenyon K.

AU - Becker, Gary J.

AU - Conces, Dewey

PY - 1989

Y1 - 1989

N2 - An open-label noncomparative clinical study was conducted to evaluate the safety, tolerance, and efficacy of ioversol (Optiray® 320), a new low-osmolality nonionic contrast medium used in contrast-enhanced computed tomographic (CT) scanning. Forty-two adult patients who required contrast-enhanced body CT scanning participated in the study. Ioversol was administered to patients undergoing CT of the chest, abdomen, and pelvis. Most of the patients received a dose of 150 mL, with smaller doses administered if a patient weighed less than 50 kg or if a patient had only one functioning kidney. The quality of the CT scans was judged to be diagnostic in all 42 patients in the study, with the quality assessed as excellent in 35 patients and good in seven patients. Ioversol was considered well tolerated by patients in the study, with none reporting any pain from the contrast agent. Only mild or moderate sensations of heat were reported. There were no clinically significant changes in vital signs, and only one mild adverse reaction (determined to be procedure-related) was reported. Ioversol was found to be safe, well tolerated, and efficacious for use in body CT scanning.

AB - An open-label noncomparative clinical study was conducted to evaluate the safety, tolerance, and efficacy of ioversol (Optiray® 320), a new low-osmolality nonionic contrast medium used in contrast-enhanced computed tomographic (CT) scanning. Forty-two adult patients who required contrast-enhanced body CT scanning participated in the study. Ioversol was administered to patients undergoing CT of the chest, abdomen, and pelvis. Most of the patients received a dose of 150 mL, with smaller doses administered if a patient weighed less than 50 kg or if a patient had only one functioning kidney. The quality of the CT scans was judged to be diagnostic in all 42 patients in the study, with the quality assessed as excellent in 35 patients and good in seven patients. Ioversol was considered well tolerated by patients in the study, with none reporting any pain from the contrast agent. Only mild or moderate sensations of heat were reported. There were no clinically significant changes in vital signs, and only one mild adverse reaction (determined to be procedure-related) was reported. Ioversol was found to be safe, well tolerated, and efficacious for use in body CT scanning.

KW - Computed tomographic scanning

KW - Contrast medium

KW - Ioversol

UR - http://www.scopus.com/inward/record.url?scp=0024364902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024364902&partnerID=8YFLogxK

M3 - Article

C2 - 2687192

AN - SCOPUS:0024364902

VL - 24

SP - S33-S34

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

ER -